Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2006 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the Roth 2006 New York Conference

CHARLOTTE, N.C., Aug. 30, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Roth 2006 New York Conference on September 6th at 5:00 PM at the...
July 18, 2006 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Appoints Veteran Pharmaceutical Executive to Management Team

CHARLOTTE, N.C., July 18, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has appointed Keith W. Schmidt Vice President of Marketing and Sales. Mr. Schmidt's initial focus...
July 06, 2006 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present At CE Unterberg Towbin Emerging Growth Conference

CHARLOTTE, N.C., July 6, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the CE Unterberg Towbin Emerging Growth Conference at 2:28 PM EDT on...
June 26, 2006 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the Jefferies Life Sciences Conference

CHARLOTTE, N.C., June 26, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Jefferies Life Sciences Conference at 10:15 a.m. EDT on Wednesday,...
June 19, 2006 09:53 ET | Source: Chelsea Therapeutics

Phase I Results for Chelsea Therapeutics' Lead Compound CH-1504 to be Presented At EULAR 2006

CHARLOTTE, N.C., June 19, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that Dr. Ernest Choy will report data from the Company's Phase I trial of CH-1504 at the...
June 06, 2006 08:05 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at Pacific Growth Equities Life Sciences Growth Conference

CHARLOTTE, N.C., June 6, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Pacific Growth Equities Life Sciences Growth Conference at 2:00 PM...
May 30, 2006 09:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Signs Exclusive Droxidopa License Agreement With Dainippon Sumitomo Pharma

CHARLOTTE, N.C., May 30, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has entered into an exclusive license agreement with Dainippon Sumitomo Pharma Co., Ltd. (DSP) for...
May 25, 2006 08:15 ET | Source: Chelsea Therapeutics

The Journal of Rheumatology Publishes Clinical Results from Pilot Study of Chelsea Therapeutics' Lead Product Candidate CH-1504

CHARLOTTE, N.C., May 25, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that an article entitled, "Controlled Trial of Methotrexate versus CH-1504 in the...
May 09, 2006 07:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Updates Product Pipeline Status and Clinical Development Priorities

CHARLOTTE, N.C., May 9, 2006 (PRIMEZONE) -- In conjunction with the Company's recent strategic alliance and licensing agreements, Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has realigned...
May 09, 2006 07:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics and Active Biotech to Co-Develop Portfolio of Therapeutics Targeting Autoimmune Disease and Transplant Rejection

Agreement Creates Synergistic Alliance Focused on Immune-Mediated Inflammatory Disorders Chelsea to Host Conference Call to Discuss New Products and Update ...